As chairman of the Illinois Biotechnology Industry Organization.

the best exercise guide exercise get fit- not fat- karobix exercise guide

As chairman of the Illinois Biotechnology Industry Organization, Abbott Labs' Jim Tyree is fixing a serious Chicago illness: We don't spin on the outside enough entrepreneurial growth companies. Bringing BIO2006, the global industry trade point out to here April 9-12, is just the first degree in the Rx.

Tyree wants to create an entrepreneurial ecosystem allowing local biotech behemoths so as Abbott, Baxter, Takeda and Fujisawa to go on well and new startups to escape

"The city will have sexual delight with the benefit of 30 to 35 million dollars in direct

economic benefit from the 20000 visitors who will be here for BIO2006," Tyree says. That's great for cabdrivers, waiters and inn employees. But Tyree wants to do calm more than provide a short season shot in the arm for tourism incomes He is nurturing and networking Chicago's biotech industry and demonstrating it is world class.

"BIO2006 wait ons as a capstone of a three-year effort," says Tyree who believes Chicago biotech can rival industry concentrations in succession the East and West coasts. "Through BIO2006, we are bringing focus to what our region has to proffer It is substantial. We decided to make progress after BIO2006 because it gives us a chance to bring everyone to the table."

Tyree knows piece of works are moving offshore. Chicago will merely prosper through innovation, investment and entrepreneurship. We ne to create modern companies in the new knowledge industries like biotech. BIO2006 should be a great catalyst.

Chicago lags Minneapolis

Promod Haque, Norwest adventure partners managing partner and named to Forbes magazine's top chance capitalists in 2004, believes in prosperity in consequence of innovation.

"We have to latch in succession to the next generation of technology," says Haque, who was here last week to address the Indus Entrepreneur and the Illinois peril Capital Association. Haque also stopped at Motorola to trade ideas with CEO ed Zander's brain trust.

"Minneapolis is more entrepreneurial than Chicago," says Haque, who earned his MBA and doctorate at Northwestern University and has local foundations Haque isn't hammering Chicago. He is trying to help. He points to Minneapolis-based Medtronic and the wealth of startups that cascaded from the company.

Creating more entrepreneur and a forcible biotech ecosystem is precisely what iBio's Tyree has in mind.

Tyree's efforts are crucial. Working behind the shows Tyree has knit together a coalition of top leaders from industry, restraint academia and the not-for-profit sector to boost Chicago's entrepreneurial pros-pect for the in extent term.

Tyree isn't doing it alone. He's not seeking credit. He's building an ecosystem

Tyree who minister tos as senior vice president of Abbott Nutrition International, have sexual delight withs enthusiastic support from his bos Abbott Labs CEO Miles White. Without Abbott's backing, there might not be a BIO2006 in Chicago.

Then there's the $1 million provided through the state of Illinois, and the support of Mayor Daley. BIO2006 clearly is the issue of a potent public sector/ private sector partnership.

While last-minute preparations are below way for BIO2006, Tyree is looking ahead. He wants to bring the program back to Chicago in 2010 That's a great idea. After all, Chicago's too big a berg to play entrepreneurial secondary fiddle to Minneapolis.

Midwest Gateway to India

Chicago takes another pace at becoming the Midwest gateway to India when Infosys CEO Nandan Nilekani speaks at the University of Chicago Graduate train of Business Hyde Park campus Tuesday night.

Nilekani is a co-founder of the $2 billion global tech services company based in Bangalore. The fireside chat will be moderated by dint of Dean Ted Snyder. Watch for Nilekani to address the continuing flattening of the world and the skills be in want ofed to win in the of recent origin environment.

Celebrating biotech

The Economic progression in a continuously ascending gradation Council convenes Wednesday at the Tower coterie to review Chicago's biotech commercialization efforts. Members are celebrating more than $100 million in local biotech commercialization investments since the first of the year, including $44 million at the Illinois Medical District Technology Park and $50 million in funding at Northwestern, the U of C and UIC.

Speakers include: UIC professor Brenda Russell, Illinois Medical District Chief of Staff Mich Hein and UIC Assistant Vice Chancellor David Gulley

Michael Krauss is a Chicago area tech writer and consultant.

...